Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19)

Lu-Lu Yang, Ting Yang, Lu-Lu Yang, Ting Yang

Abstract

As a highly infectious respiratory tract disease, coronavirus disease 2019 (COVID-19) can cause respiratory, physical, and psychological dysfunction in patients. Therefore, pulmonary rehabilitation is crucial for both admitted and discharged patients of COVID-19. In this study, based on the newly released pulmonary rehabilitation guidelines for patients with COVID-19, as well as evidence from the pulmonary rehabilitation of patients with severe acute respiratory syndrome, we investigated pulmonary rehabilitation for patients with COVID-19 having complications, such as chronic pulmonary disease, and established an intelligent respiratory rehabilitation model for these patients.

Keywords: Coronavirus disease 2019 (COVID-19); Intelligence; Pulmonary rehabilitation.

© 2020 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Figures

Fig. 1
Fig. 1
Diffuse pulmonary lesions in both lungs of the COVID-19 patient.

References

    1. Diagnosis and Treatment Guideline for Novel Coronavirus Pneumonia . 7th ed. 2020. The People's Republic of China: National Health Commission of the People's Republic of China, General Office of the National Health Commission. at.
    1. Spruit M.A., Singh S.J., Garvey C. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–e64.
    1. Pauwels R.A., Buist A.S., Calverley P.M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276.
    1. Healthy China Initiative (2019–2030) 2019. The People's Republic of China: National Health Commission of the People's Republic of China. at.
    1. COPD Working Group Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012;12:1–75.
    1. Charususin N., Gosselink R., Decramer M. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD. Thorax. 2018;73:942–950.
    1. Gordon C.S., Waller J.W., Cook R.M., Cavalera S.L., Lim W.T., Osadnik C.R. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156:80–91.
    1. Calik-Kutukcu E., Arikan H., Saglam M. Arm strength training improves activities of daily living and occupational performance in patients with COPD. Clin Res J. 2017;11:820–832.
    1. Tarigan A.P., Pandia P., Mutiara E., Pradana A., Rhinsilva E., Efriyandi E. Impact of lower-limb endurance training on dyspnea and lung functions in patients with COPD. Open Access Maced J Med Sci. 2018;6:2354–2358.
    1. Liu Y., Su N., Shen C., Jiang A.D. Literature analysis on the efficacy and safety of lopinavir/ritonavir in viral infectious diseases (in Chinese) Herald Med. 2020;3:1–15.
    1. Khalid M., Al Rabiah F., Khan B., Al Mobeireek A., Butt T.S., Al Mutairy E. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases. Antivir Ther. 2015;20:87–91.
    1. Stockman L.J., Bellamy R., Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343.
    1. Hong D.S., Wang R.R., Ye Z.Q., Rao Y.F., Xu K.J., Lu X.Y. The effect of interferon combined with ribavirin on the risk of death in patients with Severe Coronavirus Infection: a Systematic Review based on previous MERS-CoV studies (in Chinese) Chin J Hosp Pharm. 2020:1–7.
    1. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271.
    1. Chen T., Chen G., Guo W. A quick guidelinefor novel coronavirus pneumonia (Trial 3rd Edition) (in Chinese) Herald Med. 2020;39:305–307.
    1. Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J Gen Intern Med. 2020;35:1545–1549.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704.
    1. Xu Z., Shi L., Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422.
    1. Notice on Issuing Psychological Crisis Intervention Guidelines for the Novel Coronavirus Pneumonia Epidemic . 2020. The People's Republic of China:National Health Commission of the People's Republic of China. at.
    1. Hui D.S., Joynt G.M., Wong K.T. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401–409.
    1. Ng C.K., Chan J.W., Kwan T.L. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax. 2004;59:889–891.
    1. Lee N., Hui D., Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994.
    1. Herridge M.S., Cheung A.M., Tansey C.M. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683–693.
    1. Lau H.M., Ng G.Y., Jones A.Y., Lee E.W., Siu E.H., Hui D.S. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51:213–219.
    1. Huang Z., Wang N.H., Lan Y., Li M., Chen R. Rehabilitation for the patients with severe acute respiratory syndrome in remission (in Chinese) Chin J Rehabil Med. 2004;10:15–17.
    1. Chinese Association of Rehabilitation Medicine Respiratory rehabilitation committee of Chinese association of rehabilitation medicine, cardiopulmonary rehabilitation group of Chinese society of physical medicine and rehabilitation. Recommendations for respiratory rehabilitation of COVID-19 in adults (in Chinese) Chin J Tubere Respir Dis. 2020;43:308–314.
    1. Xie Y.X. Rehabilitation treatment of patients with COVID-19 (in Chinese) Rehabil Med. 2020;30:1.
    1. Nonoyama M.L., Brooks D., Lacasse Y., Guyatt G.H., Goldstein R.S. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007:CD005372.
    1. Henderson R.C., Specter B.B. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr. 1994;125:208–212.
    1. Rassouli F., Boutellier D., Duss J., Huber S., Brutsche M.H. Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study. Int J Chronic Obstr Pulm Dis. 2018;13:3831–3836.
    1. Bourne S., DeVos R., North M. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open. 2017;7

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe